ArticleThe Journal of clinical investigation2014

Integrin-mediated type II TGF-β receptor tyrosine dephosphorylation controls SMAD-dependent profibrotic signaling.

Xiwu Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.